期刊文献+

N-端脑钠肽前体测定在高血压疾病中的应用研究 被引量:4

Application on NT-proBNP in Patients with Essential Hypertension
下载PDF
导出
摘要 目的:探讨血清 N端脑钠肽前体(NT-proBNP)在高血压疾病的应用研究。方法选择152例高血压患者纳入研究,根据高血压病情发展分为高血压1级(30例),高血压2级(36例)和高血压3级(86例)。86例高血压3级患者根据有无并发糖尿病又分为单纯高血压组(40例)和高血压并发糖尿病组(46例),分别比较不同分级组的血清 NT-proBNP水平变化。结果高血压1级患者、2级患者和3级患者血清中 NT-proBNP水平分别为68±44,122±31和834±309 pg/ml。随着病情发展其血清水平逐渐升高(t=2.455,3.561,P<0.01),高血压3级患者中高血压并发糖尿病组和单纯高血压组血清中NT-proBNP分别为1178±664 pg/ml和599±411 pg/ml(t=3.785,P<0.01)。结论 NT-proBNP水平能客观反映高血压患者的病情程度,对临床治疗和病情监测有一定的指导意义。 Objective To study the N terminal pro brain natriuretic peptide (NT-proBNP)in serum of hypertension patients. Methods 152 patients with hypertension were included in this study.According to the different degree and development of hypertension,152 patients were divided into three different grade group of hypertension:first grade of hypertension group (30 patients),second grade of hypertension group (36 patients)and third grade of hypertension group (86 patients).And the 86 patients were divided into hypertension group (40 patients)and hypertension with diabetes group (46 patients)re-spectively,comparaed with the level of NT-proBNP in serum of different hypertension grade groups.Results The levels of the NT-proBNP in serum were 68±44,122±31 and 834±309 pg/ml of first grade of hypertension group,second grade of hypertension group and third grade of hypertension group,respectively.The level of the NT-proBNP was gradually increased with grade of hypertension (t=2.455,3.561,P〈0.01).The level of the NT-proBNP (1 178±864 pg/ml)of hypertension with diabetes group was significantly higher than hypertension group (599±411 pg/ml)(t=3.785,P〈0.01).Conclusion The level of NT-proBNP can obj ectively reflect the grade of the disease in patients with hypertension.it is a certain signifi-cance guiding for monitoring the clinical treatment of the disease.
出处 《现代检验医学杂志》 CAS 2016年第5期100-102,共3页 Journal of Modern Laboratory Medicine
关键词 脑钠肽 N-端脑钠肽前体 高血压 糖尿病 BNP NT-proBNP Hypertension diabetes
  • 相关文献

参考文献1

二级参考文献9

  • 1Maisel AS,Koon J,Krishnaswamy P,et al. Utility of B-natriuretic peptide as a rapid point-of-care test for screening patients undergoin echo-cardiography to determine left ventricular dysfunction [J]. Am Heart J, 2001,141 (3) : 367-374.
  • 2Wieczorek SJ,Wu AH,Christenson R,et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure :a multi- center evaluation[J]. Am Heart J, 2002,144 (5) : 834- 839.
  • 3Lee SC, Stevens TL, Sandberg SM, et al. The poten-tial of brain natriuretic peptide as a biomarker for New York heart association class during the outpa- tient treatment of heart failure[J]. Journal of Cardiac Failure,2002,8 (3) : 149-154.
  • 4Groenning BA, Nilsson JC, Sondergaard L,et al. E- valuation of impaired left ventriccular ejection frac- tion and increased dimensions by multiple neurohu- moral plasma concentrations[J]. Eur J Heart Fail, 2001,3(6) :699-708.
  • 5Lubien E, I)eMaria A,Krishnaswamy P,et al. Utility of B-natriuretic peptide in detecting diastolic dys- function: comparison with Doppler velocity record- ings [J] Circulation, 2002,105 (5) : 595-601.
  • 6Selvais PL,Donckier JE,Robert A,et al. Cardiac na- triuretic peptides for diagnosis and risk stratification in heart failure :influences of left ventricular dysfunc- tion and coronary artery disease on cardiac hormonal activation [J]. Eur J Clin Invest, 1998, 28 (8) : 636- 642.
  • 7Krishnaswamy P, Lubien E,Clopton P,et al. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction [J]. Am J Med, 2001,111 (4) : 274-279.
  • 8Alan Maise,Christian Mueller,W. Frank Peacock,Gerasimos Filippatos,Hu Dayi,胡大一(主译),刘梅颜(主译),吴寸草(翻译),王博雅(翻译),黄睿(翻译).2008中西方BNP专家共识[J].中国医药导刊,2009,11(10):1628-1637. 被引量:77
  • 9李卫鹏,郑佐娅.B型钠尿肽研究进展[J].国外医学(临床生物化学与检验学分册),2004,25(3):260-262. 被引量:16

共引文献6

同被引文献15

引证文献4

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部